Application of antineoplastic polypeptide TT-1 in preparing antineoplastic medicines
An anti-tumor drug, TT-1 technology, applied in the field of biomedicine, can solve the problems of high cost of polypeptide production, high toxicity, and poor stability of polypeptides to proteasomes
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0011] Example 1 In vitro inhibitory activity of polypeptide TT-1 on human thyroid ductal carcinoma TT cells
[0012] Take TT cells in the logarithmic growth phase, adjust the cell concentration to 5×10 with F12K medium containing 10% FBS 4 cells / ml, 100 μl of cell suspension was added to a 96-well culture plate, and 20 μl / well of different concentrations of TT-1 diluted with culture medium were added (final concentrations were: 0, 1, 2, 4, 8, 16, 32 μg / well, respectively). ml), 37℃, 5%CO 2 After culturing for 48 hours, aspirate the supernatant, add 80 μl of fresh culture medium, then add 20 μl of 5 mg / ml MTT to each well, continue to cultivate for 4 hours, centrifuge, carefully aspirate the supernatant, add 150 μl DMSO to each well, shake gently to make The formazan was completely dissolved, and the absorbance was measured with a microplate reader at a wavelength of 570 nm. The cell viability was calculated according to literature, cell viability (%)=(average absorbance of ...
Embodiment 2
[0014] Example 2 Inhibitory activity of polypeptide TT-1 on human thyroid ductal carcinoma TT cells in vivo
[0015] Human thyroid ductal carcinoma TT cells in the logarithmic growth phase were diluted with normal saline, stained with trypan blue and counted under an inverted microscope with a hemocytometer. The number of viable cells was above 98%, and the cell concentration was adjusted to 4×10 7 / ml, subcutaneously inoculate 0.1ml of cells in the right side of the armpit of nude mice, and wait until the tumor volume of the mice grows to 50mm 3 At that time, they were randomly divided into 4 groups: tumor model group, TT-1 low, medium and high dose treatment groups, 6 rats in each group. TT-1 low, medium and high dose groups were 0.04, 0.2, 1mg / kg, administered once every 5 days, each injection of 50 μl of drug, the tumor model group was injected with the same amount of normal saline each time, and the administration methods were the same. For intratumoral injection. The a...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com